AstraZeneca Pharma India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ASTRAZEN BSE: 506820

About AstraZeneca Pharma India Limited

No company profile on record yet.

Key facts

BSE symbol506820
NSE symbolASTRAZEN
ISININE203A01020
CINL24231KA1979PLC003563
Listing date4 May 2001
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorM/s. Makarand M. Joshi & Co., Company Secretaries (Mr. Omkar Dindorkar)
Registered officeBLOCK N1, 12TH FLOOR, MANYATA EMBASSY BUSINESS PARK, RACHENAHALLI, OUTER RING ROAD
Registrar & transfer agentIntegrated Registry Management Services Private Limited 30, RAMANA RESIDENCY, 4TH CROSS, SAMPIGE ROAD, MALLESHWARAM, BANGALORE- 560 003

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)2,304†—1,330†1,029†820†
Net profit1881161629962†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
BHAVANA AGRAWALExecutive DirectorJune 30, 2026
PRAVEEN RAO AKKINEPALLYExecutive DirectorJune 30, 2026
MONICA WIDHANIIndependent DirectorJune 30, 2026
REVATHY ASHOKIndependent DirectorJune 30, 2026
SHILPA DIVEKAR NIRULAIndependent DirectorJune 30, 2026
HOOI BIEN CHUAHNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.